Valuation : Cegedim

Market Cap 142M 165M 134M 122M 228M 15.58B 229M 1.58B 613M 7.99B 620M 606M 25.75B P/E 2026 *
6.78x
P/E 2027 * 5.17x
Enterprise Value 304M 353M 286M 261M 489M 33.37B 490M 3.38B 1.31B 17.12B 1.33B 1.3B 55.16B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 165M
+3.08%+5.26%-31.80%+28.07% 457B
+0.05%-2.95%-18.65%+44.77% 249B
-2.97%-2.38%-22.71%+18.28% 146B
-1.39%+12.17%-57.48%+308.88% 54.87B
-0.57%-4.41%-34.26%+6.85% 46.32B
-16.68%-19.18%-39.15%+4.43% 20.13B
+0.06%-3.41%-17.64%+56.67% 19.62B
-1.05%-2.52%-26.34%+11.22% 13.87B
-19.93%-21.10%-37.70%+88.71% 13.52B
Average -3.94%-2.50%-31.75%+63.10% 113.42B
Weighted average by Cap. +0.26%+1.31%-28.66%+45.53%

Financials

2026 *2027 *
Net sales 660M 766M 621M 567M 1.06B 72.37B 1.06B 7.33B 2.85B 37.13B 2.88B 2.82B 120B 684M 795M 644M 588M 1.1B 75.06B 1.1B 7.61B 2.95B 38.51B 2.99B 2.92B 124B
Net income 21.3M 24.75M 20.04M 18.31M 34.25M 2.34B 34.34M 237M 91.89M 1.2B 92.95M 90.92M 3.86B 28M 32.54M 26.34M 24.07M 45.02M 3.07B 45.14M 311M 121M 1.58B 122M 120M 5.08B
Net Debt 162M 188M 153M 139M 261M 17.79B 261M 1.8B 700M 9.13B 708M 692M 29.41B 134M 155M 126M 115M 215M 14.68B 216M 1.49B 577M 7.53B 584M 571M 24.26B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-